EMA Substance Additions

The EMA’s Human Medicines Under Evaluation list will be reviewed monthly to create relevant substances into the SNOMED CT Substances hierarchy.

Method:

Filter to previous month
Remove outliers, such as:
- Combination products. These are often older/existing substances going through the approval process because it’s the first time a product is using them together; e.g., “Sufentanil / Ketamine”
- Vaccines. Tend not to display a true ‘substance’ name, e.g., “Rabies vaccine for human use prepared in cell cultures”
- Cell therapies. Tend not to display a true ‘substance’ name, e.g., “Autologous melanoma-derived tumor infiltrating lymphocytes”

Terms for addition into CRS:

See ‘New concept’ tab.